Global Omeprazole Market was treasured at US$ 2,668.4 million in 2017 and is expected to grow at a CAGR of 5.2% over the forecast period. This market is segmented by dosage form (tablet, capsule, and powder), indication (erosive esophagitis, duodenal ulcer, gastroesophageal reflux disease (GERD), and gastric ulcer), distribution channel (online pharmacies, hospital pharmacies, and retail pharmacies), and region (Africa, North America, Latin America, Middle East, Europe, Asia Pacific,) from 2018 to 2026.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/2380
Market participants are launching affordable generics to boost the market growth. The rising prevalence of stomach ulcers brought on by H. pylori infection and the usage of nonsteroidal anti-inflammatory drugs (NSAIDs) are two factors that are predicted to contribute to the considerable expansion of the worldwide omeprazole market over the forecast period. According to a 2016 study by the Deccan College of Medical Sciences, Helicobacter pylori is thought to be the cause of 95% of duodenal ulcers and 70% of stomach ulcers. The study also revealed that NSAID usage is connected to 14–25% of gastric and duodenal ulcers. Additionally, in order to increase market sales, developers are concentrating on the development and introduction of affordable generic versions of omeprazole.
For instance, in July 2017, Breckenridge Pharmaceutical, Inc.’s (Breckenridge) abbreviated new drug application (ANDA) for Omeprazole postponed capsules and received FDA approval. The parent company, Laboratorios Dr. Esteve, S.A., will manufacture and provide the drug.
A persistent digestive illness called gastroesophageal reflux disease (GERD) occurs when stomach acid leaks into the esophagus, inflaming it. The illness causes a severe and persistent form of acid reflux. The National Institute of Diabetes and Digestive and Kidney Diseases estimates that between 15.1 and 30 percent of Americans have GERD. Additionally, GERD is the most prevalent gastroenterology-related outpatient diagnostic condition in the US, accounting for over nine million primary care visits each year, according to the Department of Gastroenterology at Cedars-Sinai Medical Center 2014. The market participants are concentrating on creating therapies that relieve heartburn by utilizing cutting-edge technology.
Omeprazole 20mg orally disintegrating tablets (ODT) with cutting-edge MelTech melt-in-your-mouth technology was introduced in April 2018 by Perrigo Company plc and Dexcel Pharma Technologies, Ltd. Modern technology provides an affordable OTC alternative.
Due to the rising frequency of peptic ulcer and acid-related disorders as well as the regulatory bodies’ approval of generic versions, the worldwide omeprazole market is anticipated to see a CAGR of 5.2% during the forecast period. For instance, Perrigo Company plc. launched a brand of omeprazole OTC pills in 2016 after receiving FDA clearance from the United States. Zegerid OTC is used to relieve persistent heartburn.
Due to the greater number of discount coupons given for generic and over-the-counter omeprazole medications, the online pharmacy segment is anticipated to have a leading position in the omeprazole market in 2026.
Lek Pharmaceuticals d.d., AstraZeneca Plc., Watson Laboratories, Inc., Sandoz, Inc., Santarus, Inc., Mylan N.V., Perrigo Company Plc., Apotex, Inc., Impax Laboratories, Inc., and Dr. Reddy’s Labs, Inc., are a few of the main companies active in the worldwide omeprazole market.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/2380
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Omeprazole Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Omeprazole Industry Impact
Chapter 2 Global Omeprazole Competition by Types, Applications, and Top Regions and Countries
2.1 Global Omeprazole (Volume and Value) by Type
2.3 Global Omeprazole (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Omeprazole Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Omeprazole Market Analysis
Chapter 6 East Asia Omeprazole Market Analysis
Chapter 7 Europe Omeprazole Market Analysis
Chapter 8 South Asia Omeprazole Market Analysis
Chapter 9 Southeast Asia Omeprazole Market Analysis
Chapter 10 Middle East Omeprazole Market Analysis
Chapter 11 Africa Omeprazole Market Analysis
Chapter 12 Oceania Omeprazole Market Analysis
Chapter 13 South America Omeprazole Market Analysis
Chapter 14 Company Profiles and Key Figures in Omeprazole Business
Chapter 15 Global Omeprazole Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/2380
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027